Clinical Trial Update: UNIVERSAL 1: Pharmacokinetic Study of a Novel DTG/FTC/TAF Dose Ratio for Children [Phase 2]

View source ↗

Summary

Phase 2 pharmacokinetic study in children evaluating a novel fixed-dose ratio of dolutegravir/emtricitabine/tenofovir alafenamide has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Emtriva (emtricitabine)
• Tivicay (dolutegravir)
• Vemlidy (tenofovir alafenamide)

Snippet

Sponsor: PENTA Foundation | Conditions: HIV Infection | Phase 2 | Status: COMPLETED